MRI of the gastrointestinal tract

European Radiology

Volumn 7, Issue 9, 1997, Pages 1387-1397

  Paley, M R ^a   Ros, P R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Benign neoplasms; Congenital abnormalities; Gastrointestinal tract; Inflammatory diseases; Magnetic resonance imaging; Malignant neoplasms

Indexed keywords

CONTRAST MEDIUM;

DIGESTIVE SYSTEM; DIGESTIVE SYSTEM MALFORMATION; ENTERITIS; GASTROINTESTINAL TUMOR; HISTOLOGY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

CONTRAST MEDIA; DIGESTIVE SYSTEM; DIGESTIVE SYSTEM ABNORMALITIES; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING;

EID: 0031300173     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050306     Document Type: Article

References (74)

1. Gelfand DW, Ott DJ, Chen YM (1987) Decreasing numbers of gastrointestinal studies: report of data from 69 radiologic practices. AJR 148 (6): 1133-1136
2. Mirowitz SA (1993) Contrast enhancement of the gastrointestinal tract on MR images using intravenous gadolinium-DTPA. Abdom Imaging 18 (3): 215-219
3. Shoenut JP, Semelka RC, Silverman R et al. (1993) Magnetic resonance imaging in inflammatory bowel disease. J Clin Gastroenterol 17 (1): 73-78
4. Shoenut JP, Semelka RC, Magro CM et al. (1994) Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease. J Clin Gastoenterol 19 (1): 31-35
5. Panaccione JL, Ros PR, Torres GM et al. (1991) Rectal barium in pelvic MR imaging: initial results. J Magn Reson Imaging 1: 605-607
6. Kressel HY (1991) Insights of an abdominal imager: What do we need for MRI enhancement? Magn Reson Med 22: 314-318
7. Hahn PF (1991) Advances in contrast enhanced MR imaging. Gastrointestinal contrast agents. AJR 156 (2): 252-254
8. Brown JJ (1996) Gastrointestinal contrast agents for MR imaging. MRI Clin North Am 4 (1): 25-35
9. Ballinger JR (1993) Contrast agents. In: Ros PR, Bidgood WD Jr (eds) Abdominal magnetic resonance imaging. Mosby Year-Book, St. Louis, pp 116-120
10. Rijcken THP, Davis MA, Ros PR (1994) Intraluminal contrast agents fo MR imaging of the abdomen and pelvis. J Magn Reson Imaging 4: 291-300
11. Wan X, Wedeking P, Tweedle MF (1994) Sources of heterogenous contrast enhancement in the gastrointestinal tract. Magn Reson Imaging 12 (7): 1009-1012
12. Patten RM, Moss AA, Fenton TA et al. (1992) OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics. J Magn Reson Imaging 2: 25-34
13. Hirohashi S, Uchida H, Yoshikawa K et al. (1994) Large-scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Reson Imaging 12: 837-846
14. Kaminsky S, Laniado M, Gogoll M et al. (1991) Gadopentate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178: 503-508
15. Li KCP, Ho-Tai PCK (1990) The search for the ideal enteric MR contrast agent. Diagn Imaging 3: 110-114
16. Unger EC, Fritz TA, Palestrant D et al. (1993) Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent. J Magn Reson Imaging 3 (1): 119-124
17. Tilcock C, Unger EC, Ahkong QF et al. (1991) Polymeric gastrointestinal MR contrast agents. J Magn Reson Imaging 1 (4): 463-467
18. Laniado M, Kornmesser W, Hamm B et al. (1988) MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 150 (4): 817-821
19. Hiraishi K, Narabayashi I, Fujita O et al. (1995) Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 194 (1): 119-123
20. Tart RP, Li KCP, Storm BL et al. (1991) MR contrast agents: comparative study of five potential agents in humans. Magn Reson Imaging 9: 559-568
21. Mirowitz SA, Susman N (1992) Use of nutritional support formula as a gastrointestinal contrast agent for MRI. J Comput Assist Tomogr 16 (6): 908-915
22. Balzarini L, Aime S, Barbero L et al. (1992) Magnetic resonance imaging of the gastointestinal tract: investigation of baby milk as a low-cost contrast medium. Eur J Radiol 15 (2): 171-174
23. Vlahos L, Gouliamos A, Athanasopoulou A et al. (1994) A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastrointestinal (GI) contrast agents for MRI of the abdomen. Magn Reson Imaging 12 (5): 719-726
24. Hahn PF, Stark DD, Lewis JM et al. (1990) First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175 (3): 695-700
25. Rubin DL, Muller HH, Sidhu MK et al. (1993) Liquid oral magnetic particles as a gastrointestinal contrast agent for MR imaging: efficacy in vivo. J Magn Reson Imaging 3 (1): 113-118
26. Niemi P, Katevuo K, Kormano M et al. (1990) Superparamagnetic particles as gastrointestinal contrast agent in magnetic resonance imaging of the lower abdomen. Acta Radiol 31 (4): 409-411
27. Liebig T, Stoupis C, Ros PR et al. (1993) A potentially artifact-free oral contrast agent for gastrointestinal MRI. Magn Reson Imaging 30: 646-649
28. MitchellDG, Vinitski S, Mohamed FB et al. (1991) Comparison of kaopectate with barium for negative and positive enteric contrast at MR imaging. Radiology 181: 475-480
29. Ros PR, Steinman RM, Torres GM et al. (1991) The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers. AJR 157 (4): 761-767
30. Langmo L, Ros PR, Torres GM et al. (1992) Comparison of MR imaging after barium administration with CT in pelvic disease J Magn Reson Imaging 2: 89-91
31. Kraus BB, Rappaport DC, Ros PR et al. (1994) Evaluation of oral contrast agents for abdominal magnetic resonance imaging. Magn Reson Imaging 12 (6): 847-858
32. Mattrey RF, Hajek PC, Gylys-Morin VM et al. (1987) Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans. AJR 148 (6): 1259-1263
33. Anderson CM, Brown JJ, Balfe DM et al. (1994) MR imaging of Crohn's disease: use of perflubron as a gastrointesinal contrast agent. J Magn Reson Imaging 4 (3): 491-496
34. Brown JJ, Duncan JR, Heiken JP et al. (1991) Perflouroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 181 (2): 455-460
35. Hocking M, Young DC (1981) Duplications of the alimentary tract. Br J Surg 68: 92-96
36. Lupetin AR, Dash N (1987) MRI appearance of esophageal duplication cyst. Gastrointest Radiol 12: 7-9
37. Schatzkes D, Gordon DH, Haller JO et al. (1990) Malrotation of the bowel: malalignment of the superior mesenteric artery-vein complex shown by CT and MR. J Comput Assist Tomogr 14 (1): 93-95
38. Sachs TM, Applebaum H, Touran T (1990) Use of MRI in evaluation of anorectal anomalies. J Pediatr Surg 25 (7): 817-821
39. McHugh K, Dudley NE, Tam P (1995) Pre-operative MRI of anorectal anomalies in the newborn period. Pediatr Radiol 25 (S1): S33-S36
40. Giovagnoni A, Misericordia M, Terilli F et al. (1993) MR imaging in ulcerative colitis. Abdom Imaging 18: 371-375
41. Sugimura K, Carrington BM, Quivey JM et al. (1990) Postirradiation changes in the pelvis: assessment with MR imaging. Radiology 175: 805-813
42. Haggett PJ, Moore NR, Shearman JD et al. (1995) Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging. Gut 36: 407-410
43. Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula in ano. Dr J Surg 63: 1-12
44. Spencer JA, Ward J, Beckingham IJ et al. (1996) Dynamic contrast-enhanced MR imaging of perianal fistulas. AJR 167: 735-741
45. Myhr GE, Myrvold HE, Nilsen G et al. (1994) Perianal fistulas: use of MR imaging for diagnosis. Radiology 191: 545-549
46. Barker PG, Lunniss PJ, Armstrong P et al. (1994) Magnetic resonance imaging of fistula-in-ano: technique, interpretation and accuracy. Clin Radiol 49: 7-13
47. Koebel G, Schmiedel U, Majer MC et al. (1989) Diagnosis of fistulae and sinus tracts in patients with Crohn's disease: value of MR imaging. AJR 152: 999-1003
48. Younathan CM, Ros PR, Burton SS (1991) MR imaging of colonic lipoma. J Comput Assist Tomogr 15 (3): 492-494
49. Hölscher AH, Dittler HJ, Siewert JR (1994) Staging of squamous esophageal cancer: accuracy and value. World J Surg 18: 312-320
50. Takashima S, Takeuchi N, Shiozaki H et al. (1991) Carcinoma of the esophagus: CT vs MR imaging in determining resectability. AJR 156: 297-302
51. Chou CK, Chen LT, Sheu RS et al. (1994) MRI manifestations of gastrointestinal wall thickening. Abdom Imaging 19 (5): 389-394
52. Winkler ML, Hricak H, Higgins CB (1987) MR imaging of diffusely infiltrating gastric carcinoma. J Comput Assist Tomogr 11 (2): 337-339
53. Chou CK, Chen LT, Sheu RS et al. (1994) MRI manifestations of gastrointestinal lymphoma. Abdom Imaging 19 (6): 495-500
54. Halvorsen RA, Yee J, McCormick VD (1996) Diagnosis and staging of gastric cancer. Semin Oncol 23 (3): 325-335
55. Matsushita M, Hiromichi O, Murakami T et al. (1994) Extraserosal invasion in advanced gastric cancer: evaluation with MR imaging. Radiology 192: 87-91
56. Ohnishi T, Yoshioka H, Ishida O (1991) MR imaging of gastrointestinal leiomyosarcoma. Radiat Med 9 (3): 114-117
57. Theoni RF (1991) Colorectal cancer: cross-sectional imaging for staging of primary tumor and detection of local recurrence. AJR 156: 909-915
58. Shoenut PJ, Semelka RC, Silverman R et al. (1993) Magnetic resonance imaging evaluation of the local extent of colorectal mass lesions. J Clin Gastroenterol 17: 248-253
59. Hodgman CG, MacCarty RL, Wolff BG et al. (1986) Preoperative staging of rectal carcinoma by computed tomography and 0.15T magnetic resonance imaging. Dis Colon Rectum 29: 446-450
60. Guinet C, Buy JN, Ghossain MA et al. (1990) Comparison of magnetic resonance imaging and computed tomography in the preoperative staging of rectal cancer. Arch Surg 125: 385-388
61. Theoni R, Moss AA, Schnyder P et al. (1981) Detection and staging of primary rectal and rectosigmoid cancer by computed tomography. Radiology 141: 135-138
62. Freeny PC, Marks WM, Ryan JA et al. (1986) Colorectal carcinoma: evaluation with CT: preoperative staging and detection of postoperative recurrence. Radiology 158: 347-353
63. Zerhouni EA, Ruther C, Hamilton SR et al. (1996) CT and MR imaging in the staging of colorectal carcinoma: report of the radiology Diagnostic Oncology Group II. Radiology 200: 443-451
64. Schnall MD, Furth EE, Rosato EF et al. (1994) Rectal tumor stage: correlation of endorectal MR imaging and pathologic findings. Radiology 190: 709-714
65. Rifkin MD, Ehrlick SM, Marks G (1989) Staging of rectal carcinoma: prospective comparison of endorectal ultrasound and CT. Radiology 170: 319-322
66. Mendenhall WM, Million RR, Bland KI et al. (1985) Preoperative radiation therapy for clinically resectable adenocarcinoma of the rectum. Cancer 102: 215-222
67. Mohiuddin M, Marks GJ (1987) High dose preoperative radiation and sphincter preservation in the treatment of rectal cancer. Int J Radiat Oncol Biol Phys 13: 839-842
68. Lange EE de, Fechner RE, Spaulding CA et al. (1992) Rectal carcinoma treated by preoperative irradiation: MR imaging and histopathologic correlation. AJR 158: 287-292
69. Lange EE de (1994) Staging rectal carcinoma with endorectal imaging: How much detail do we really need? Radiology 190: 633-635
70. Olson RM, Perencevich NP, Malcolm AW et al. (1980) Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 45: 2969-2974
71. Lee JKT, Stanley RJ, Sagel SS et al. (1981) CT appearances of the pelvis after abdominoperineal resection for rectal carcinoma. Radiology 141: 737-741
72. Lange EE de, Fechner RE, Wanebo HJ (1989) Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology 170: 323-328
73. Trenkner SW, Thompson WM (1993) Imaging of recurrent carcinoma of the gastrointestinal tract. Radiol Clin North Am 31 (6): 1255-1264
74. Strauss LG, Clorius JH, Schlag P et al. (1989) Recurrence of colorectal tumors: PET evaluation. Radiology 170: 329-332